Hanne Bendiksen Skogvold

  • Spesialingeniør; MSc
  • +47 230 70 911

Status: On maternity leave until June 2025

Education

  • 2024: PhD in Analytical Chemistry, University of Oslo, Norway
  • 2017: MSc in Analytical Chemistry, University of Oslo, Norway
  • 2015: BSc in Engineering (Biotechnology and chemistry), Oslo Metropolitan University, Norway

Affiliation

Research Summary

Dr. Skogvold specializes in analytical method development and metabolomics in clinical research and diagnostics. Her bachelor’s thesis focused on method development for metabolomics analysis of dried blood spots using LC-QTOF MS. Hanne's master’s thesis involved optimizing mass spectrometric parameters for metabolomics analysis of dried blood spots using LC-Orbitrap MS.

Highlights:

  • A new methods paper, adding valuable information to the field of Clinical Metabolomics: Skogvold et al. (2021)
  • A novel metabolomics study of human 3-NPA intoxication, reporting the 1st case in Norway and the 2nd in Scandinavia: Skogvold et al. (2021)

Work Experience

  • 2023-to date: Spesialingeniør, Department of Medical Biochemistry, Oslo University Hospital, Norway
  • 2019-2023: PhD Research Fellow, Oslo Metropolitan University + Oslo University Hospital, Norway
  • 2018 July-December: Engineer at the Department of Medical Biochemistry, Oslo University Hospital, Norway
  • 2018 January-June: Research Assistant at the Department of Mechanical, Electronic and Chemical Engineering, Oslo Metropolitan University + Department of Medical Biochemistry, Oslo University Hospital, Norway
  • 2017 August-December: Engineer at the Department of Medical Biochemistry, Oslo University Hospital, Norway

Links

NB: Visit our NEWS PAGE for the latest updates and our Gallery for group social events!

 

Publications 2025

Skogvold HB, Sand ES, Elgstøen KBP (2025)
Global Metabolomics Using LC-MS for Clinical Applications
Methods Mol Biol, 2855, 23-39
DOI 10.1007/978-1-0716-4116-3_2, PubMed 39354299

Publications 2023

Skogvold HB, Rootwelt H, Reubsaet L, Elgstøen KBP, Wilson SR (2023)
Dried blood spot analysis with liquid chromatography and mass spectrometry: Trends in clinical chemistry
J Sep Sci, 46 (15), e2300210
DOI 10.1002/jssc.202300210, PubMed 37269205

Skogvold HB, Wilson SRH, Rønning PO, Ferrante L, Opdal SH, Rognum TO, Rootwelt H, Elgstøen KBP (2023)
A global metabolomics minefield: Confounding effects of preanalytical factors when studying rare disorders
Anal Sci Adv, 4 (7-8), 255-266
DOI 10.1002/ansa.202300010, PubMed 38716308

Publications 2022

Böhm HO, Yazdani M, Sandås EM, Østeby Vassli A, Kristensen E, Rootwelt H, Skogvold HB, Brodtkorb E, Elgstøen KBP (2022)
Global Metabolomics Discovers Two Novel Biomarkers in Pyridoxine-Dependent Epilepsy Caused by ALDH7A1 Deficiency
Int J Mol Sci, 23 (24)
DOI 10.3390/ijms232416061, PubMed 36555701

Publications 2021

Bendiksen Skogvold H, Yazdani M, Sandås EM, Østeby Vassli A, Kristensen E, Haarr D, Rootwelt H, Elgstøen KBP (2021)
A pioneer study on human 3-nitropropionic acid intoxication: Contributions from metabolomics
J Appl Toxicol, 42 (5), 818-829
DOI 10.1002/jat.4259, PubMed 34725838

Skogvold HB, Sandås EM, Østeby A, Løkken C, Rootwelt H, Rønning PO, Wilson SR, Elgstøen KBP (2021)
Bridging the Polar and Hydrophobic Metabolome in Single-Run Untargeted Liquid Chromatography-Mass Spectrometry Dried Blood Spot Metabolomics for Clinical Purposes
J Proteome Res, 20 (8), 4010-4021
DOI 10.1021/acs.jproteome.1c00326, PubMed 34296888

Scroll to top